{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,22]],"date-time":"2026-03-22T09:58:05Z","timestamp":1774173485864,"version":"3.50.1"},"reference-count":24,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1016\/j.ejphar.2011.11.046","type":"journal-article","created":{"date-parts":[[2011,12,8]],"date-time":"2011-12-08T16:57:31Z","timestamp":1323363451000},"page":"57-63","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Oxicam structure in non-steroidal anti-inflammatory drugs is essential to exhibit Akt-mediated neuroprotection against 1-methyl-4-phenyl pyridinium-induced cytotoxicity"],"prefix":"10.1016","volume":"676","author":[{"given":"Yoshikazu","family":"Tasaki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joe","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomohiro","family":"Omura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshihiro","family":"Noda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoya","family":"Kamiyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichi","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Machiko","family":"Satomi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoki","family":"Sakaguchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaru","family":"Asari","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoko","family":"Ohkubo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiko","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuo","family":"Matsubara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2011.11.046_bb0005","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1742-2094-4-1","article-title":"All-trans retinoic acid induces COX-2 and prostaglandin E2 synthesis in SH-SY5Y human neuroblastoma cells: involvement of retinoic acid receptors and extracellular-regulated kinase 1\/2","volume":"4","author":"Alique","year":"2007","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.ejphar.2011.11.046_bb0010","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1001\/archneur.60.8.1059","article-title":"Nonsteroidal anti-inflammatory drugs and the risk of Parkinson disease","volume":"60","author":"Chen","year":"2003","journal-title":"Arch. Neurol."},{"key":"10.1016\/j.ejphar.2011.11.046_bb0015","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1046\/j.1471-4159.1999.0731409.x","article-title":"Extracellular-regulated kinases and phosphatidylinositol 3-kinase are involved in brain-derived neurotrophic factor-mediated survival and neuritogenesis of the neuroblastoma cell line SH-SY5Y","volume":"73","author":"Encinas","year":"1999","journal-title":"J. Neurochem."},{"key":"10.1016\/j.ejphar.2011.11.046_bb0020","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.expneurol.2007.02.008","article-title":"Non-steroidal anti-inflammatory drugs in Parkinson's disease","volume":"205","author":"Esposito","year":"2007","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.ejphar.2011.11.046_bb0025","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.2146\/ajhp050514","article-title":"Treatment of rheumatoid arthritis","volume":"63","author":"Gaffo","year":"2006","journal-title":"Am. J. Health-Syst. Pharm."},{"key":"10.1016\/j.ejphar.2011.11.046_bb0030","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1007\/s10571-011-9671-8","article-title":"Akt as a victim, villain and potential hero in Parkinson's Disease pathophysiology and treatment","volume":"31","author":"Greene","year":"2011","journal-title":"Cell. Mol. Neurobiol."},{"key":"10.1016\/j.ejphar.2011.11.046_bb0035","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/S0006-8993(02)03216-X","article-title":"Methylpyridinium (MPP(+))- and nerve growth factor-induced changes in pro- and anti-apoptotic signaling pathways in SH-SY5Y neuroblastoma cells","volume":"952","author":"Halvorsen","year":"2002","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2011.11.046_bb0040","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1212\/01.wnl.0000204446.82823.28","article-title":"Nonsteroidal anti-inflammatory drugs and the incidence of Parkinson disease","volume":"66","author":"Hernan","year":"2006","journal-title":"Neurology"},{"key":"10.1016\/j.ejphar.2011.11.046_bb0045","doi-asserted-by":"crossref","first-page":"11397","DOI":"10.1074\/jbc.275.15.11397","article-title":"The cyclooxygenase-2 inhibitor celecoxib induces apoptosis by blocking Akt activation in human prostate cancer cells independently of Bcl-2","volume":"275","author":"Hsu","year":"2000","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2011.11.046_bb0050","first-page":"6697","article-title":"Adenoviral-mediated expression of a kinase-dead mutant of Akt induces apoptosis selectively in tumor cells and suppresses tumor growth in mice","volume":"63","author":"Jetzt","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.ejphar.2011.11.046_bb0055","doi-asserted-by":"crossref","first-page":"R796","DOI":"10.1186\/bcr1294","article-title":"Celecoxib analogues disrupt Akt signaling, which is commonly activated in primary breast tumours","volume":"7","author":"Kucab","year":"2005","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.ejphar.2011.11.046_bb0060","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.biopha.2006.06.017","article-title":"Selective cyclooxygenase inhibition: its role in pain and anaesthesia","volume":"60","author":"Langford","year":"2006","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.ejphar.2011.11.046_bb0070","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1196\/annals.1332.007","article-title":"Inflammation and the degenerative diseases of aging","volume":"1035","author":"McGeer","year":"2004","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.ejphar.2011.11.046_bb0065","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1212\/WNL.38.8.1285","article-title":"Reactive microglia are positive for HLA-DR in the substantia nigra of Parkinson's and Alzheimer's disease brains","volume":"38","author":"McGeer","year":"1988","journal-title":"Neurology"},{"key":"10.1016\/j.ejphar.2011.11.046_bb0075","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.neulet.2007.12.034","article-title":"Caffeine activates the PI3K\/Akt pathway and prevents apoptotic cell death in a Parkinson's disease model of SH-SY5Y cells","volume":"432","author":"Nakaso","year":"2008","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ejphar.2011.11.046_bb0080","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/ana.20338","article-title":"Microglial activation and dopamine terminal loss in early Parkinson's disease","volume":"57","author":"Ouchi","year":"2005","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.ejphar.2011.11.046_bb0085","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.expneurol.2004.06.021","article-title":"Involvement of dopamine D(2)\/D(3) receptors and BDNF in the neuroprotective effects of S32504 and pramipexole against 1-methyl-4-phenylpyridinium in terminally differentiated SH-SY5Y cells","volume":"190","author":"Presgraves","year":"2004","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.ejphar.2011.11.046_bb0090","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1007\/s11064-008-9779-5","article-title":"The effects of piroxicam in the attenuation of MPP+\/MPTP toxicity in vitro and in vivo","volume":"34","author":"Soliman","year":"2009","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.ejphar.2011.11.046_bb0095","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1093\/jnci\/90.20.1529","article-title":"Cyclooxygenase-2 inhibitors in tumorigenesis (part I)","volume":"90","author":"Taketo","year":"1998","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.ejphar.2011.11.046_bb0100","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.brainres.2010.04.085","article-title":"Meloxicam protects cell damage from 1-methyl-4-phenyl pyridinium toxicity via the phosphatidylinositol 3-kinase\/Akt pathway in human dopaminergic neuroblastoma SH-SY5Y cells","volume":"1344","author":"Tasaki","year":"2010","journal-title":"Brain Res."},{"key":"10.1016\/j.ejphar.2011.11.046_bb0105","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/1098-2396(200102)39:2<167::AID-SYN8>3.0.CO;2-U","article-title":"Inhibition of the cyclooxygenase isoenzymes COX-1 and COX-2 provide neuroprotection in the MPTP-mouse model of Parkinson's disease","volume":"39","author":"Teismann","year":"2001","journal-title":"Synapse"},{"key":"10.1016\/j.ejphar.2011.11.046_bb0110","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.neulet.2009.09.055","article-title":"Akt signal transduction dysfunction in Parkinson's disease","volume":"467","author":"Timmons","year":"2009","journal-title":"Neurosci. Lett."},{"key":"10.1016\/j.ejphar.2011.11.046_bb0115","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1002\/mds.20856","article-title":"Nonsteroidal anti-inflammatory drugs and risk of Parkinson's disease","volume":"21","author":"Ton","year":"2006","journal-title":"Mov. Disord."},{"key":"10.1016\/j.ejphar.2011.11.046_bb0120","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1096\/fj.04-2457fje","article-title":"MPP+-induced COX-2 activation and subsequent dopaminergic neurodegeneration","volume":"19","author":"Wang","year":"2005","journal-title":"FASEB J."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299911015135?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299911015135?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T22:14:59Z","timestamp":1757974499000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299911015135"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2]]},"references-count":24,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["S0014299911015135"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2011.11.046","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2012,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oxicam structure in non-steroidal anti-inflammatory drugs is essential to exhibit Akt-mediated neuroprotection against 1-methyl-4-phenyl pyridinium-induced cytotoxicity","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2011.11.046","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2011 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}